Calcitonin Gene Related Peptide (CGRP) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update
Powered by
All the vital news, analysis, and commentary curated by our industry experts.
Calcitonin Gene-Related Peptide (CGRP) is derived mainly from the cell bodies of motor neurons when synthesized in the ventral horn of the spinal cord and contributes to the regeneration of nervous tissue after injury. CGRP plays an important role in cardiovascular homeostasis and nociception.
The CGRP pipeline market research report provides comprehensive information on the CGRP targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA), and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history, the latest news as well as press releases. Additionally, the report provides an overview of key players involved in Calcitonin Gene Related Peptide (CGRP) targeted therapeutics development with respective active and dormant or discontinued projects.
Key Therapy Areas in the CGRP Pipeline Products Market
The key therapy areas in the CGRP pipeline products market are central nervous system, immunology, and oncology.
CGRP Pipeline Products Market Analysis by Therapy Areas
For more therapy area insights, download a free report sample
Key Mechanisms of Action in the CGRP Pipeline Products Market
The key mechanism of action in the CGRP pipeline products market is Calcitonin Gene Related Peptide Inhibitor.
Key Routes of Administration in the CGRP Pipeline Products Market
The key routes of administration in the CGRP pipeline products market are subcutaneous, intravenous, intramuscular, oral, and topical.
CGRP Pipeline Products Market Analysis by Routes of Administration
For more routes of administration insights, download a free report sample
Key Molecule Types in the CGRP Pipeline Products MarketThe key molecule types in the CGRP pipeline products market are monoclonal antibody, small molecule, gene therapy, peptide, subunit vaccine, and synthetic peptide.
The key molecule types in the CGRP pipeline products market are monoclonal antibody, small molecule, gene therapy, peptide, subunit vaccine, and synthetic peptide.
CGRP Pipeline Products Market Analysis by Molecule Types
For more molecule type insights, download a free report sample
Major Companies in the CGRP Pipeline Products Market
The major companies in the CGRP pipeline products market are Acherx LLC, AfaSci Inc, Eli Lilly and Co, H. Lundbeck AS, Kissei Pharmaceutical Co Ltd, Nepsone ehf, Pharmnovo AB, Shandong Boan Biotechnology Co Ltd, Shanghai Junshi Bioscience Co Ltd, Teva Pharmaceutical Industries Ltd, and Vaxxinity Inc.
CGRP Pipeline Products Market Analysis by Companies
To know more about major companies, download a free report sample
CGRP Pipeline Products Market Report Overview
Key Therapy Areas | Central Nervous System, Immunology, and Oncology |
Key Mechanisms of Action | Calcitonin Gene Related Peptide Inhibitor |
Key Routes of Administration | Subcutaneous, Intravenous, Intramuscular, Oral, and Topical |
Key Molecule Type | Monoclonal Antibody, Small Molecule, Gene Therapy, Peptide, Subunit Vaccine, and Synthetic Peptide |
Major Companies | Acherx LLC, AfaSci Inc, Eli Lilly and Co, H. Lundbeck AS, Kissei Pharmaceutical Co Ltd, Nepsone ehf, Pharmnovo AB, Shandong Boan Biotechnology Co Ltd, Shanghai Junshi Bioscience Co Ltd, Teva Pharmaceutical Industries Ltd, and Vaxxinity Inc |
Scope
- The report provides a snapshot of the global therapeutic landscape for Calcitonin Gene Related Peptide (CGRP) Calcitonin Gene Related Peptide (CGRP)
- The report reviews Calcitonin Gene Related Peptide (CGRP) targeted therapeutics under development by companies and universities/research institutes based on information derived from company and industry-specific sources
- The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages
- The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing, and collaboration details & other developmental activities
- The report reviews key players involved in Calcitonin Gene Related Peptide (CGRP) targeted therapeutics and enlists all their major and minor projects
- The report assesses Calcitonin Gene Related Peptide (CGRP) targeted therapeutics based on mechanism of action (MoA), route of administration (RoA), and molecule type
- The report summarizes all the dormant and discontinued pipeline projects
- The report reviews the latest news and deals related to Calcitonin Gene Related Peptide (CGRP) targeted therapeutics
Reasons to Buy
- Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies
- Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage
- Identify and understand the targeted therapy areas and indications for Calcitonin Gene Related Peptide (CGRP)
- Identify the use of drugs for target identification and drug repurposing
- Identify potential new clients or partners in the target demographic
- Develop strategic initiatives by understanding the focus areas of leading companies
- Plan mergers and acquisitions effectively by identifying key players and their most promising pipeline therapeutics
- Devise corrective measures for pipeline projects by understanding Calcitonin Gene Related Peptide (CGRP) development landscape
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
AfaSci Inc
Eli Lilly and Co
H. Lundbeck AS
Kissei Pharmaceutical Co Ltd
Nepsone ehf
Pharmnovo AB
Shandong Boan Biotechnology Co Ltd
Shanghai Junshi Bioscience Co Ltd
Teva Pharmaceutical Industries Ltd
Vaxxinity Inc
Table of Contents
Table
Figures
Frequently asked questions
-
What are the key therapy areas in the CGRP pipeline products market?
The key therapy areas in the CGRP pipeline products market are central nervous system, immunology, and oncology.
-
What are the key mechanisms of action in the CGRP pipeline products market?
The key mechanism of action in the CGRP pipeline products market is Calcitonin Gene Related Peptide Inhibitor.
-
What are the key routes of administration in the CGRP pipeline products market?
The key routes of administration in the CGRP pipeline products market are subcutaneous, intravenous, intramuscular, oral, and topical.
-
What are the key molecule types in the CGRP pipeline products market?
The key molecule types in the CGRP pipeline products market are monoclonal antibody, small molecule, gene therapy, peptide, subunit vaccine, and synthetic peptide.
-
Which are the major companies in the CGRP pipeline products market?
The major companies in the CGRP pipeline products market are Acherx LLC, AfaSci Inc, Eli Lilly and Co, H. Lundbeck AS, Kissei Pharmaceutical Co Ltd, Nepsone ehf, Pharmnovo AB, Shandong Boan Biotechnology Co Ltd, Shanghai Junshi Bioscience Co Ltd, Teva Pharmaceutical Industries Ltd, and Vaxxinity Inc.
Get in touch to find out about multi-purchase discounts
reportstore@globaldata.com
Tel +44 20 7947 2745
Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.